Pharmaceutical ETFs-Watch Out For Democrats!
January 3rd at 1:00pm by Tom Lydon
Pharmaceutical exchange traded funds (ETFs) could see the effects of a Democrat-controlled Congress on the horizon. Peter Benesh of Investor’s Business Daily writes that drug makers, pharmacy benefit managers and drug distributors will take the first hits. Leading Democrats promise to bring in legislation that will allow Medicare to negotiate drug prices with suppliers. Medicare’s bargaining power could push drug prices down across the board. Generic drugs won’t get a boost either, partly because the trend is already established and they offer higher profit margins than brands. Pharmaceutical ETFs to keep an eye on include:
